Carson Wealth (CWM LLC)
CASC

Carson Wealth (CWM LLC)’s Cascadian Therapeutics, Inc. CASC Stock Holding History

Carson Wealth (CWM LLC)’s Portfolio CASC Stock Details CASC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-55
Closed – – 1625
2017
Q4 		$0 Hold
55
– – ﹤0.01% 1649
2017
Q3 		$0 Hold
55
– – ﹤0.01% 1620
2017
Q2 		$0 Buy
+55
New +$218 ﹤0.01% 1372

Carson Wealth (CWM LLC)'s CASC Position: Q1 2018 in Review

Carson Wealth (CWM LLC) sold out of Cascadian Therapeutics, Inc. (CASC) in Q1 2018, closing a stake of 55 shares.

Carson Wealth (CWM LLC) first reported a position in CASC in Q2 2017 and held it in 3 quarters. The position peaked at $0 in Q4 2017. 1 fund tracked by Wall St. Rank holds CASC as of Q1 2018.

  • Carson Wealth (CWM LLC) reported no remaining Cascadian Therapeutics, Inc. position as of Q1 2018 after selling out during the quarter.
  • Carson Wealth (CWM LLC) sold 55 Cascadian Therapeutics, Inc. shares in Q1 2018.
  • Carson Wealth (CWM LLC) first reported a position in Cascadian Therapeutics, Inc. in Q2 2017 and held it in 3 quarters.
  • Carson Wealth (CWM LLC)'s Cascadian Therapeutics, Inc. position peaked at $0 in Q4 2017.
  • 1 fund tracked by Wall St. Rank held Cascadian Therapeutics, Inc. as of Q1 2018.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2018, filed 26 Apr 2018.